How Complement and FcRn Inhibitors Are Changing gMG Treatment

adicionou um novo artigo Health

2025-06-18 11:40:05

Generalized Myasthenia Gravis (gMG) is a chronic, autoimmune neuromuscular disorder characterized by fluctuating skeletal muscle weakness. Driven by autoantibodies that impair neuromuscular transmission, gMG affects voluntary muscles involved in eye movement, swallowing, breathing, and limb activity. Advances in immunology and biologics have shifted the therapeutic landscape from broad...

0 Comentários 0 Compartilhamentos 30 Visualizações 0 Anterior